(Q40192276)

English

Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients

scientific article published on November 1, 1978

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients (English)

1 reference

10.1016/0033-0620(78)90025-7

https://api.crossref.org/works/10.1016/0033-0620(78)90025-7

13 January 2023

Cardiology and cardiovascular medicine

1 reference

10.1016/0033-0620(78)90025-7

https://api.crossref.org/works/10.1016/0033-0620(78)90025-7

13 January 2023

author name string

D. B. Case

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A214819

13 January 2023

S. A. Atlas

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A214819

13 January 2023

J. H. Laragh

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A214819

13 January 2023

J. E. Sealey

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A214819

13 January 2023

P. A. Sullivan

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A214819

13 January 2023

D. N. McKinstry

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A214819

13 January 2023

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=214819

13 January 2023

publication date

1 November 1978

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:0033062078900257?httpAccept=text/xml

1 reference

10.1016/0033-0620(78)90025-7

https://api.crossref.org/works/10.1016/0033-0620(78)90025-7

13 January 2023

https://api.elsevier.com/content/article/PII:0033062078900257?httpAccept=text/plain

1 reference

10.1016/0033-0620(78)90025-7

https://api.crossref.org/works/10.1016/0033-0620(78)90025-7

13 January 2023

Progress in Cardiovascular Diseases

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

195-206

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases

1

1 reference

10.1016/0033-0620(78)90025-7

https://api.crossref.org/works/10.1016/0033-0620(78)90025-7

13 January 2023

Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension

2

1 reference

10.1016/0033-0620(78)90025-7

https://api.crossref.org/works/10.1016/0033-0620(78)90025-7

13 January 2023

Rapid identification of patients with essential hypertension sensitive to acebutolol (a new cardioselective beta-blocker)

3

1 reference

10.1016/0033-0620(78)90025-7

https://api.crossref.org/works/10.1016/0033-0620(78)90025-7

13 January 2023

Unexpected pressor responses to propranolol in essential hypertension. An interaction between renin, aldosterone and sympathetic activity

5

1 reference

10.1016/0033-0620(78)90025-7

https://api.crossref.org/works/10.1016/0033-0620(78)90025-7

13 January 2023

Use of an Angiotensin II Antagonist (Saralasin) in the Recognition of “Angiotensinogenic” Hypertension

6

1 reference

10.1016/0033-0620(78)90025-7

https://api.crossref.org/works/10.1016/0033-0620(78)90025-7

13 January 2023

Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients

8

1 reference

10.1016/0033-0620(78)90025-7

https://api.crossref.org/works/10.1016/0033-0620(78)90025-7

13 January 2023

Blockade and stimulation of renal, adrenal, and vascular angiotensin II receptors with 1-Sar, 8-Ala angiotensin II in normal man

9

1 reference

10.1016/0033-0620(78)90025-7

https://api.crossref.org/works/10.1016/0033-0620(78)90025-7

13 January 2023

Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting Enzyme

10

1 reference

10.1016/0033-0620(78)90025-7

https://api.crossref.org/works/10.1016/0033-0620(78)90025-7

13 January 2023

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

11

1 reference

10.1016/0033-0620(78)90025-7

https://api.crossref.org/works/10.1016/0033-0620(78)90025-7

13 January 2023

A specific orally active inhibitor of angiotensin-converting enzyme in man.

12

1 reference

10.1016/0033-0620(78)90025-7

https://api.crossref.org/works/10.1016/0033-0620(78)90025-7

13 January 2023

Inhibition of angiotensin converting enzyme by SQ 14,225 in conscious rabbits

13

1 reference

10.1016/0033-0620(78)90025-7

https://api.crossref.org/works/10.1016/0033-0620(78)90025-7

13 January 2023

Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man

15

1 reference

10.1016/0033-0620(78)90025-7

https://api.crossref.org/works/10.1016/0033-0620(78)90025-7

13 January 2023

Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease

16

1 reference

10.1016/0033-0620(78)90025-7

https://api.crossref.org/works/10.1016/0033-0620(78)90025-7

13 January 2023

Simplified Radioimmunoassay for Serum Aldosterone Utilizing Increased Antibody Specificity

19

1 reference

10.1016/0033-0620(78)90025-7

https://api.crossref.org/works/10.1016/0033-0620(78)90025-7

13 January 2023

Aldosterone excretion. Physiological variations in man measured by radioimmunoassay or double-isotope dilution

20

1 reference

10.1016/0033-0620(78)90025-7

https://api.crossref.org/works/10.1016/0033-0620(78)90025-7

13 January 2023

Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations

21

1 reference

10.1016/0033-0620(78)90025-7

https://api.crossref.org/works/10.1016/0033-0620(78)90025-7

13 January 2023

Identifiers

10.1016/0033-0620(78)90025-7

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40192276&oldid=1810517085"